Literature DB >> 32171751

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Heuser1, Y Ofran2, N Boissel3, S Brunet Mauri4, C Craddock5, J Janssen6, A Wierzbowska7, C Buske8.   

Abstract

Entities:  

Keywords:  European LeukaemiaNet; World Health Organization; acute myeloid leukaemia; dosing information; guideline; treatment recommendation

Mesh：

Year:  2020        PMID： 32171751     DOI： 10.1016/j.annonc.2020.02.018

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  43 in total

1.  A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients.

Authors:  Mi Jin Oh; Dong-Yeop Shin; Youngil Koh; Junshik Hong; Inho Kim; Sung-Soo Yoon; Ja Min Byun
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.

Authors:  Michael Heuser; Bennet Heida; Konstantin Büttner; Clara Philine Wienecke; Katrin Teich; Carolin Funke; Maximilian Brandes; Piroska Klement; Alessandro Liebich; Martin Wichmann; Blerina Neziri; Anuhar Chaturvedi; Arnold Kloos; Konstantinos Mintzas; Verena I Gaidzik; Peter Paschka; Lars Bullinger; Walter Fiedler; Albert Heim; Wolfram Puppe; Jürgen Krauter; Konstanze Döhner; Hartmut Döhner; Arnold Ganser; Michael Stadler; Lothar Hambach; Razif Gabdoulline; Felicitas Thol
Journal:  Blood Adv       Date:  2021-05-11

3.  Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients.

Authors:  Mercy Gatua; Mohsen Navari; Matilda Ong'ondi; Noel Onyango; Serah Kaggia; Emily Rogena; Giuseppe Visani; Nicholas A Abinya; Pier Paolo Piccaluga
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

Review 4.  How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia.

Authors:  Jozal W Moore; Nancy Torres; Michael Superdock; Jason H Mendler; Kah Poh Loh
Journal:  Curr Treat Options Oncol       Date:  2022-06-10

Review 5.  Oncology stewardship in acute myeloid leukemia.

Authors:  Madeleine A Ochs; Bernard L Marini; Anthony J Perissinotti; Charles E Foucar; Kristen Pettit; Patrick Burke; Dale L Bixby; Lydia L Benitez
Journal:  Ann Hematol       Date:  2022-05-26       Impact factor: 4.030

Review 6.  2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies.

Authors:  Vittoria Raimondi; Giulia Ciotti; Michele Gottardi; Francesco Ciccarese
Journal:  Biomedicines       Date:  2022-06-09

7.  Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.

Authors:  Kathrin Heinrich; Lisa Miller-Phillips; Frank Ziemann; Korbinian Hasselmann; Katharina Rühlmann; Madeleine Flach; Dorottya Biro; Michael von Bergwelt-Baildon; Julian Holch; Tobias Herold; Louisa von Baumgarten; Philipp A Greif; Irmela Jeremias; Rachel Wuerstlein; Jozefina Casuscelli; Christine Spitzweg; Max Seidensticker; Bernhard Renz; Stefanie Corradini; Philipp Baumeister; Elisabetta Goni; Amanda Tufman; Andreas Jung; Jörg Kumbrink; Thomas Kirchner; Frederick Klauschen; Klaus H Metzeler; Volker Heinemann; C Benedikt Westphalen
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.322

8.  Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.

Authors:  Kazuhito Yamamoto; Atsushi Shinagawa; Courtney D DiNardo; Keith W Pratz; Kenichi Ishizawa; Toshihiro Miyamoto; Norio Komatsu; Yasuhiro Nakashima; Chikashi Yoshida; Noriko Fukuhara; Kensuke Usuki; Takahiro Yamauchi; Noboru Asada; Norio Asou; Ilseung Choi; Yasushi Miyazaki; Hideyuki Honda; Sumiko Okubo; Misaki Kurokawa; Ying Zhou; Jiuhong Zha; Jalaja Potluri; Itaru Matsumura
Journal:  Jpn J Clin Oncol       Date:  2022-01-03       Impact factor: 2.925

9.  Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL.

Authors:  Julia K Bialek-Waldmann; Sabine Domning; Ruth Esser; Wolfgang Glienke; Mira Mertens; Krasimira Aleksandrova; Lubomir Arseniev; Suresh Kumar; Andreas Schneider; Johannes Koenig; Sebastian J Theobald; Hsin-Chieh Tsay; Angela D A Cornelius; Agnes Bonifacius; Britta Eiz-Vesper; Constanca Figueiredo; Dirk Schaudien; Steven R Talbot; Andre Bleich; Loukia M Spineli; Constantin von Kaisenberg; Caren Clark; Rainer Blasczyk; Michael Heuser; Arnold Ganser; Ulrike Köhl; Farzin Farzaneh; Renata Stripecke
Journal:  Mol Ther Methods Clin Dev       Date:  2021-04-09       Impact factor: 6.698

Review 10.  Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes.

Authors:  Katerina E Miari; Monica L Guzman; Helen Wheadon; Mark T S Williams
Journal:  Front Cell Dev Biol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.